InsidersTradesSigma
Follow the 팜젠사이언스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 팜젠사이언스 has logged 91 reports. Market capitalisation: €75.4bn. The latest transaction was reported on 12 May 2026 (Purchase). Among the most active insiders: 한의상. The full history is accessible without an account.
91
Insider Decl.
n/a
Thresholds
€2m
72 ops.
Buy Volume
n/a
3 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,057 of 29,055 companies
33.9
score / 100
Value31
Quality37
FCF yld3.8%
Earn yld-166%
EV/EBITDA·
ROE0.1%
Gross mgn65%
Net mgn-67%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 May 2026
Declarations91 total
25 of 91 declarations
Acerca de 팜젠사이언스
Farmgen Science es una empresa del sector de la salud y farmacéutico que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones farmacéuticas innovadoras.